학술논문

Tonic pupil after botulinum toxin-A injection for treatment of esotropia in children
Document Type
article
Source
Journal of American Association for Pediatric Ophthalmology and Strabismus. 20(1)
Subject
Biomedical and Clinical Sciences
Ophthalmology and Optometry
Infectious Diseases
Prevention
Clinical Research
Emerging Infectious Diseases
Adolescent
Botulinum Toxins
Type A
Child
Child
Preschool
Esotropia
Female
Humans
Infant
Injections
Intramuscular
Male
Neuromuscular Agents
Oculomotor Muscles
Pilot Projects
Tonic Pupil
Pediatric Eye Disease Investigator Group
Clinical Sciences
Ophthalmology & Optometry
Clinical sciences
Ophthalmology and optometry
Language
Abstract
A total of 27 children with esotropia (mean age, 3.9 years; range, 9 months to 13.8 years) were enrolled in a 9-month observational study following botulinum toxin A (BTX-A) injection of one (n = 7) or both (n = 20) medial rectus muscles. BTX-A dosage ranged from 3.0 to 6.0 units per muscle. Three participants developed tonic pupil, noted at the first follow-up visit, occurring 12-19 days after injection. All 3 cases occurred in the left eye of participants who underwent bilateral BTX-A injection by the same surgeon. Anisocoria diminished from a maximum of 4 mm at the 2-week visit to 1-2 mm in all patients over the 9-month postinjection data collection period. No adverse visual outcomes were noted. Tonic pupil is an infrequently reported complication of BTX-A injection for strabismus. The experience of our investigator group suggests the need for careful injection technique and thorough preinjection counseling.